Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
03/2005
03/30/2005CN1602426A Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
03/30/2005CN1602355A Human fibroblast growth factor-related compositions
03/30/2005CN1602201A Peptides and related compounds having thrombopoietic activity
03/30/2005CN1194986C Type-c hepatitis virus high-variation-zone 1 synthesized peptide and use thereof
03/29/2005US6872838 Derivatives of water insoluble drugs which exhibit good activity and water solubility
03/29/2005US6872702 Cyclic peptide; antitumor agents; antiinflammatory agents; tissue remodeling
03/29/2005US6872536 Chemotactic peptide antagonists for imaging sites of inflammation
03/29/2005US6872520 Peptide for use in the detection of viral infection and diseases
03/29/2005CA2195745C Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
03/24/2005WO2005026733A1 Method and device for detecting feline immunodeficiency virus
03/24/2005WO2005026323A2 Stationary phases and a purification process using the stationary phases
03/24/2005WO2005026195A1 Biopanning as an approach to study the pathogenesis of and produce novel treatment modalities for invasive aspergillosis
03/24/2005WO2005025607A1 Methods of stimulating innate immunity using cationic peptides
03/24/2005WO2005025514A2 Compounds that modulate neuronal growth and their uses
03/24/2005WO2004103266A3 Protein kinase c peptides for use in withdrawal
03/24/2005WO2004063212A3 Organic compounds with biological action as thrombin inhibitors and use therof
03/24/2005WO2004056309A3 Neuroprotective activity of activated protein c is independent of its anticoagulant activity
03/24/2005WO2003045973A8 Peptides with growth inhibitory action
03/24/2005WO2000078801A9 Insulin-like growth factor agonist molecules
03/24/2005US20050065074 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
03/24/2005US20050065072 Bactericides; immobilized
03/24/2005US20050065070 Peptide inhibitors of LFA-1/1Cam-1 interaction
03/24/2005US20050065068 Methods and compositions for reducing serum phosphate levels
03/24/2005US20050064520 New assays for preimplantation factor and preimplantation factor peptides
03/24/2005CA2538069A1 Effectors of innate immunity determination
03/24/2005CA2537574A1 Stationary phases and a purification process using the stationary phases
03/24/2005CA2537429A1 Method and device for detecting feline immunodeficiency virus
03/24/2005CA2535279A1 Compounds that modulate neuronal growth and their uses
03/23/2005EP1516184A2 Cell penetrating peptides
03/23/2005EP1515985A2 Methods of screening molecular libraries for active molecules that restore the function of mutant p53
03/23/2005EP1515745A1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
03/23/2005CN1599753A Gene regulatory peptides
03/23/2005CN1599749A Peptides promoting cell adherence, growth and secretion
03/23/2005CN1599622A Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease
03/23/2005CN1599577A Peptide-based multimeric targeted contrast agents
03/23/2005CN1597953A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6869608 Peptides derived from a retrovirus of the HIV group and their use
03/22/2005CA2134761C Synthetic peptide vaccines for dental caries
03/17/2005WO2005024058A2 Compounds for the treatment of diseases involving cognitive impairment, such as alzheimer’s disease, and methods for identifying such compounds
03/17/2005WO2005024057A1 Method of identifying a compound that changes the amyloid-beta precursor protein processing in a cell
03/17/2005WO2005023866A2 Peptides that inhibit complement activation
03/17/2005WO2005023861A2 Gdnf-related neuropeptides
03/17/2005WO2005023857A2 Agent derived from tortoise spleen stimulating mammalian hemopoiesis
03/17/2005WO2005023846A1 New antitumoral compounds
03/17/2005WO2005023845A2 Cyclic peptides acting as urotensin-ii antagonists
03/17/2005WO2005023836A2 Peptide-based diblock and triblock dispersants and diblock polymers
03/17/2005WO2005023834A2 Peptides and compounds that bind to thrombopoietin receptors
03/17/2005WO2005023284A1 Ion channel modulators
03/17/2005WO2004113378A3 Control of lactation and peptides therefore
03/17/2005WO2004111078A3 Compounds that modulate the glucagon response and uses thereof
03/17/2005WO2004083243A8 Amylin aggregation inhibitors and use thereof.
03/17/2005WO2004076473A3 Androgen receptor interacting peptides
03/17/2005WO2004075843A3 Glycosolated enkephalin agents
03/17/2005WO2004069165A3 Methods and compositions for the treatment of gastrointestinal disorders
03/17/2005WO2003051835A3 Methods and compositions for the inhibition of viral release
03/17/2005US20050059606 hexapeptides including enantiomers, stereoisomers and tautomers, used as enzyme inhibitors for prophylaxis or prevention of viral diseases
03/17/2005US20050059604 A GPCR-like protein for treating glaucoma
03/17/2005US20050059600 Chimeric natriuretic peptides
03/17/2005US20050059599 Elastin peptide analogs and uses thereof
03/17/2005US20050059058 Oligonucleotide sequences coding integral membrane proteins (ZIPA) for use as tool in identifying bactericidal agents; microbiocides; drug screening
03/17/2005US20050058993 Method and device for detecting feline immunodeficiency virus
03/17/2005US20050058992 Method and device for detecting feline immunodeficiency virus
03/17/2005CA2579635A1 Peptides that inhibit complement activation
03/17/2005CA2537128A1 New antitumoral compounds
03/16/2005EP1514876A2 Antibody against prostate stem cell antigen (PSCA)
03/16/2005EP1513874A2 Compositions and methods of use for a bombesin peptide
03/16/2005EP1513557A2 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases
03/16/2005EP1513544A2 Retroyclins: antiviral and antimicrobial peptides
03/16/2005EP1438586A4 Fret protease assays for clostridial toxins
03/16/2005EP1250358B1 Therapeutic peptides
03/16/2005EP1003775B1 Hepatitis c inhibitor peptides
03/16/2005EP0744027B1 Use of methods for identifying hydrophilic signal oligopeptides
03/16/2005CN1596266A Specific binding agents of human angiopoietin-2
03/16/2005CN1192796C Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
03/15/2005US6867284 Fluorinated oligopeptides especially those having 4,4-difluoro- 2-amino butyric acid at the C terminus
03/15/2005US6867186 Anticancer agents
03/15/2005US6867182 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof
03/15/2005US6867179 Methods of inducing hair growth and coloration
03/15/2005US6867176 Method for preparing zinc-oligopeptide easily absorbable by the human body
03/15/2005US6866848 Diagnosis and therapy of immune disorders induced by inhibitors of blood-coagulation factor VIII and inhibitors to binding of von Willebrand factor and/or membrane phosphatides
03/15/2005US6866837 Bombesin analogs wherein the first and optionally the third amino acid are modified bind to gastrin releasing peptide receptors
03/15/2005CA2255659C Neuroactive peptides
03/10/2005WO2005021584A2 Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus
03/10/2005WO2005005436A3 Cross-linked glycopeptide-cephalosporin antibiotics
03/10/2005WO2004003166A3 Antibodies and uses thereof
03/10/2005WO2003104260A3 Pharmaceutical formulation
03/10/2005WO2003072542A3 Interfacial biomaterials
03/10/2005US20050054827 Conotoxin amino acid sequences for use as tool in controlling pain; immunotherapy; mimetics
03/10/2005US20050054825 Osteogenic devices
03/10/2005US20050054770 Helicomimetics and stabilized lxxll peptidomimetics
03/10/2005US20050054752 The peptides are optionally linked with a variety of hydrophilic and hydrophobic linkers; compositions have utility for attaching pigments and dyes to print media in a selective fashion
03/10/2005US20050054576 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
03/10/2005US20050054575 Peptide agonists of prostate-specific antigen and uses therefor
03/10/2005US20050054573 Kit for detection, monitoring kinase, phosphatase; mixture of peptides; detectable compound; adjustment proteolytic sensitivity
03/10/2005US20050054052 Therapeutic cytokine for use in prevention and treatment of viral diseases
03/10/2005US20050054026 Lipid-peptide-polymer conjugates for long blood circulation and tumor specific drug delivery systems
03/10/2005US20050054024 Fluorescent assays for protein kinases
03/10/2005CA2536570A1 Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus
03/09/2005EP1512697A1 TNF Receptor action modulation
1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 423